Cargando…
Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal
Highly glycolytic cancer cells excrete lactate to maintain cellular homeostasis. Inhibiting lactate export by pharmacological targeting of plasma membrane lactate transporters is being pursued as an anti-cancer therapy. Work from many laboratories show that the simultaneous inhibition of lactate exp...
Autores principales: | Benjamin, Don, Hall, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637960/ https://www.ncbi.nlm.nih.gov/pubmed/36353534 http://dx.doi.org/10.3389/fonc.2022.1034397 |
Ejemplares similares
-
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018) -
Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
por: Deschuymer, Sarah, et al.
Publicado: (2018) -
Combined Modality Approaches in the Management of Adult Glioblastoma
por: Shirazi, Haider A., et al.
Publicado: (2011) -
Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
por: Faisal, Muhammad, et al.
Publicado: (2017) -
Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions
por: Greenberger, Benjamin A., et al.
Publicado: (2019)